Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

3 Dividend-Paying Pharmaceutical Stocks Rated Strong Buy in the POWR Ratings

Stock Markets Dec 10, 2021 01:30PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. 3 Dividend-Paying Pharmaceutical Stocks Rated Strong Buy in the POWR Ratings
 
PFE
+0.72%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BMY
+0.96%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
IXIC
+3.34%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Since the equity markets are expected to remain uncertain in the near term on several concerns, we think it could be wise to scoop up dividend-paying pharmaceutical stocks, given the industry’s defensive nature. Betting on dividend-paying pharmaceutical stocks Pfizer (PFE), Merck (MRK), and Bristol-Myers Squibb (BMY) should help generate a steady income stream to dodge market volatility. These stocks also have an overall ‘Strong Buy’ rating in our proprietary rating system. Let’s discuss.After the three major stock market indexes posted three straight days of gains, the S&P 500 and Nasdaq Composite ended lower yesterday ahead of key inflation data and nagging COVID-19 omicron variant fears. Amid this market uncertainty, we think it could be wise to bet on quality pharmaceutical stocks, given the industry’s defensive nature. Companies in this space typically witness steady demand for their products and services irrespective of the economic conditions.

Moreover, the industry is expected to grow going forward as the population ages and chronic diseases rise. According to a LINCHPIN report, the pharmaceutical industry is expected to increase to $1.5 trillion by 2023.

Therefore, we think dividend-paying quality pharmaceutical stocks Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (MRK), and Bristol-Myers Squibb Company (NYSE:BMY) could be solid additions to one’s portfolio to secure a steady income stream. They each have an overall Strong Buy rating in our POWR Ratings system.

Continue reading on StockNews

3 Dividend-Paying Pharmaceutical Stocks Rated Strong Buy in the POWR Ratings
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email